Frequently Asked Questions

Yes. Voshell’s compounds peptide formulations that are permissible under current FDA guidance for 503A compounding pharmacies, prepared under a valid prescription from a licensed provider. Peptide therapy is a rapidly evolving clinical area, and our pharmacists remain current on FDA enforcement posture and USP standards to ensure every formulation we prepare is compliant at the time of dispensing.

Voshell’s compounds peptides that are on the current 503A-permissible list and prescribed by a licensed provider for a specific patient’s therapeutic needs. Examples of categories we have formulated include: GLP-1-related peptides (where permissible), immune-modulating peptides, tissue-repair peptides, and growth-hormone-related peptides. Because FDA guidance on specific peptides can change, we ask providers to contact us directly to confirm current availability for a specific compound before writing a prescription.

The ‘gray area’ refers to peptides that have been used clinically for years but occupy uncertain regulatory status — not FDA-approved drug products, not on the FDA’s 503A bulk substances list, yet widely prescribed. Voshell’s approach: we only compound peptides from our current permissible formulation list, sourced from FDA-registered API suppliers, under a valid prescription. When the FDA updates enforcement guidance — as it did with certain peptides in 2023 and 2024 — we update our list accordingly. We do not compound substances that fall outside current 503A authority. When in doubt, we err on the side of compliance, not convenience.

This is a fair concern and one prescribers should ask every compounding pharmacy. Enforcement actions typically target pharmacies that: (1) compound bulk peptides without individual prescriptions, (2) source APIs from non-FDA-registered suppliers, or (3) make unsubstantiated health claims. Voshell’s does none of these. Every peptide formulation at Voshell’s is prepared against a patient-specific prescription, from an FDA-registered API source, with no clinical claims made by the pharmacy. Our pursuit of NABP accreditation requires third-party review of these practices as part of the accreditation process, and we maintain these standards regardless of accreditation status.

Voshell’s cannot compound: (1) peptides that the FDA has placed on the withdrawn/removed list for 503A compounding; (2) any peptide without a valid prescriber order for a specific patient; (3) peptides for ‘research use only’ or general wellness without a therapeutic diagnosis from a licensed provider. If a peptide you have previously prescribed is no longer available through us, it may reflect an FDA guidance update — contact our pharmacist team for current status and potential clinical alternatives.

Yes, always. Voshell’s does not dispense any peptide formulation without a valid prescription from a licensed provider. This is not a policy choice — it is a federal and state law requirement for 503A compounding pharmacies. If you are a patient interested in peptide therapy, speak with your healthcare provider first. If you are a provider, you can submit prescriptions through our prescriber portal at prescriber.voshellspharmacy.com.

Prescribers can submit peptide prescriptions through the Voshell’s prescriber portal at prescriber.voshellspharmacy.com (digital order submission, patient management, status tracking), electronically via your EHR or EMR system using escript (Voshell’s is set up to receive electronic prescriptions), by fax, or by phone. Before writing your first peptide prescription through Voshell’s, we recommend a brief pharmacist consultation to confirm current formulation availability and appropriate dosing form.

Voshell’s specializes in: Bioidentical Hormone Replacement Therapy (BHRT) — including customized estradiol, progesterone, and testosterone formulations; Peptide therapy — prescription-based formulations under current 503A guidelines; Veterinary compounding — flavored formulations and species-appropriate dosing for companion and large animals; Dermatology — custom topical formulations for skin conditions; Specialty dosing forms — transdermal gels, troches, sublingual drops, and slow-release capsules not available commercially.

Bioidentical Hormone Replacement Therapy (BHRT) uses hormones that are molecularly identical to those produced by the human body — including estradiol, progesterone, and testosterone. Unlike one-size-fits-all commercial hormone products, compounded BHRT can be customized to a specific patient’s hormone levels as determined by lab testing and clinical evaluation. Voshell’s compounds BHRT formulations in multiple delivery formats — troches, topical creams, capsules, and more — under a prescriber’s order. BHRT must be prescribed and monitored by a licensed provider.

Yes. Voshell’s compounds medications for companion animals (dogs, cats, rabbits) and can work with veterinarians on species-appropriate formulations for large animals. Common veterinary compounds include flavored liquids for feline medications, transdermal gels for cats, and custom-dose formulations for animals that cannot swallow standard commercial tablet sizes. Veterinary compounds require a valid veterinary prescription.

Cost varies by formulation type, ingredients, and quantity. As general reference: BHRT creams and troches typically range from $60–$120 per prescription cycle; peptide formulations vary widely based on the compound and quantity. Voshell’s provides a price estimate before dispensing — there are no surprise charges. Our team will quote your specific prescription when it is received.

Some insurance plans cover compounded medications and some do not. Coverage depends on your specific plan, the formulation, and the diagnosis. Voshell’s can provide itemized receipts and documentation to support an insurance claim or FSA/HSA reimbursement, but we cannot guarantee coverage. We recommend calling your insurance provider before filling a new compounded prescription to ask whether your plan covers compounded medications.

Yes, in most cases. FSA (Flexible Spending Account) and HSA (Health Savings Account) funds can generally be used for prescription compounded medications. Voshell’s provides itemized receipts for reimbursement documentation. Consult your FSA/HSA administrator for specifics related to your plan.

Compounded medications are priced higher than mass-manufactured drugs because they are made individually for each patient — there is no economy of scale. Four factors drive the cost:

• API sourcing: We purchase active pharmaceutical ingredients (APIs) in small quantities from FDA-registered suppliers with lot-specific Certificates of Analysis. We cannot buy in bulk at commercial manufacturer pricing.
• Quality assurance: Every batch requires potency verification, environmental monitoring, and personnel time that commercial drugs pass on to the manufacturer — not the pharmacy.
• Formulation type: Sterile preparations (injectables, eye drops) cost more than non-sterile compounds because USP <797> requires specialized cleanroom environments, additional testing, and garbed personnel.
• Preparation complexity: Some formulations require extended preparation time or specialized equipment — that labor is reflected in the price.

Voshell’s provides a price estimate before filling any prescription. There are no surprise charges.

If you have misplaced your receipt, submit a request here. Include your name, date of fill, and medication name — we will email your receipt within 2 business days. If you need an itemized breakdown for insurance, FSA, or HSA documentation, note that in your request and we will include it.

Submit a reimbursement documentation request. Most insurance plans and FSA/HSA accounts require an itemized receipt from the dispensing pharmacy plus a copy of the prescription — we can provide both. We will send the documentation package within one business day of your request.

Yes. Voshell’s ships to patients in Maryland, Delaware, Washington DC, and Pennsylvania — the jurisdictions in which we are currently licensed. Virginia licensure is in process; contact us for current status before routing Virginia patients. Medications are shipped in temperature-appropriate packaging (cold packs for temperature-sensitive formulations). Tracking is provided for every shipment. We do not ship to jurisdictions where we are not licensed to dispense.

Temperature-sensitive formulations (including many peptide preparations) are shipped with appropriate cold packs and insulated packaging to maintain stability during transit. We ship Monday through Thursday to avoid weekend delays. Expedited shipping is available for time-sensitive orders. If a package arrives damaged or shows signs of temperature excursion, contact us immediately — do not use the medication.

The three most common reasons: your provider hasn’t yet responded to our verification request, payment hasn’t been received, or your shipping address is unconfirmed. No compound leaves our facility until all three are cleared — this protects you from receiving a medication compounded under the wrong specifications or sent to the wrong address.

To resolve it quickly: check your email and texts from Voshell’s for any open requests, then call our patient line at (410) 000-0000. We can tell you exactly which step is pending and clear it on the spot. Most holds resolve same day once we hear from you.

Yes. Every temperature-sensitive shipment includes a temperature tracker card or monitoring device. This lets you verify that your medication stayed within the safe temperature range during transit. If the tracker shows a temperature excursion upon arrival — do not use the medication. Contact Voshell’s immediately and we will arrange a replacement.

Voshell’s ships via UPS Next Day Air for cold-sensitive medications requiring temperature control. Standard non-sterile compounds ship via USPS or local courier. When your order ships, tracking is sent to you automatically — make sure notification alerts from Voshell’s are enabled on your device so you receive real-time updates. For local deliveries, we use Rx4 Route.

For local courier delivery through Rx4 Route, here is what to expect:

Day before delivery: You receive an advance notification that your delivery is scheduled for the following day. Use this to plan for someone to be available to receive it.

Day of delivery: You receive a real-time tracking alert so you can follow your courier’s progress and know when to expect them.

Important: Ensure that notifications from Voshell’s and the Rx4 Route patient app are enabled on your device. Without notifications, you will not receive delivery alerts and may miss your delivery window. If you need to reschedule, contact our patient line before 10:00 AM on the scheduled delivery day.

Regulatory status depends on the specific formulation and delivery method. A nasal spray variant is FDA-approved for major depressive disorder that has proven resistant to other treatments; this must be administered within a certified clinical environment under direct monitoring. Conversely, intravenous (IV) ketamine infusions for psychiatric indications represent an “off-label” application of an FDA-approved anesthetic. While the FDA has not formally reviewed IV ketamine for antidepressant efficacy, licensed providers may legally prescribe it based on available clinical evidence. Compounded ketamine formulations are not FDA-approved products; Voshell’s maintains transparency regarding these distinctions for all patients.

Yes. Voshell’s is a 503A compounding pharmacy and does not diagnose or prescribe. A valid order from a licensed provider is mandatory before any formulation is prepared or administered. We routinely coordinate care by communicating with your prescriber’s office. If your healthcare provider requires additional information on ketamine protocols, our pharmacist team can provide a clinical information packet to assist their review.

Compounded medications are customized preparations tailored to a specific patient’s therapeutic needs under a valid prescription. Formulations such as sublingual troches or specialized IV concentrations are not mass-manufactured FDA-approved products. However, the active ingredient has a robust clinical history dating back to 1970. Voshell’s prepares these medications to exacting quality standards in our accredited facility, operating under the regulatory oversight of the Maryland Board of Pharmacy and federal guidelines.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Common dose-dependent effects include dissociation (feelings of detachment), perceptual changes, nausea, transiently elevated blood pressure, and sedation. These typically resolve shortly after the session concludes. To ensure safety, Voshell’s requires administration within a supervised clinical environment rather than unsupervised home use. Your provider will conduct a comprehensive review of side effects during the informed consent process.

Protocols are individualized based on clinical history and prescriber judgment. Many depression regimens begin with an induction series followed by periodic maintenance. Your physician determines the appropriate frequency and duration; Voshell’s does not recommend or establish specific treatment regimens.

The FDA has issued guidance expressing concern regarding unsupervised, at-home use of compounded ketamine. Voshell’s prioritizes patient safety through supervised administration, though final determination rests with your provider depending on the specific formulation required for your care.